Patents by Inventor Patrick Netter

Patrick Netter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140248324
    Abstract: The novel biomaterial fillers containing cross-linked sodium alginate and the method for manufacturing same are used in the medical field and are intended for filling tissue lesions having a layered structure of varying compositions, such as cartilage, skin or the epithelium. These novel biomaterials have the special feature of being multiphasic, composite and functionalized, for medical use and, in particular, for treating tissue lesions having a layered structure of varying compositions. The biomaterials are particularly suitable for treating focal lesions of the articular cartilage.
    Type: Application
    Filed: April 24, 2012
    Publication date: September 4, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIQUE, UNIVERSITE DE LORRAINE
    Inventors: Laurent Jacques Grossin, Jean-Claude Voegel, Pierre Gilbert Schaaf, Pierre Gillet, Christel Odette Henrionnet, Patrick Netter
  • Publication number: 20120003320
    Abstract: Particles comprising a core based on at least one biodegradable organosoluble polymer. At least a part of the surface of the particles is coated with at least one hyaluronan or a derivative thereof, the hyaluronan being a water-soluble, amphiphilic hyaluronan of which the carboxylic functions are in part transformed to form hydrophobic groups.
    Type: Application
    Filed: August 3, 2011
    Publication date: January 5, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Edith Dellacherie, Michèle Leonard, Ruxandra Gref, Patrick Netter, Elisabeth Payan
  • Publication number: 20050271730
    Abstract: The invention relates to particles comprising a core based on at least one biodegradable organo-soluble polymer. The inventive particles are characterised in that at least part of the surface thereof is coated with at least one hyaluronan or one of the derivatives thereof, said hyaluronan being a water-soluble, amphiphilic hyaluronan of which the carboxylic functions are in part transformed in order to form hydrophobic groups.
    Type: Application
    Filed: July 21, 2003
    Publication date: December 8, 2005
    Applicant: centre national de la recherche scientifique
    Inventors: Edith Dellacherie, Michele Leonard, Ruxanda Gref, Patrick Netter, Elisabeth Payan
  • Publication number: 20040138159
    Abstract: The invention is directed toward oligonucleotides capable of directly or indirectly modulating the expression of the gene encoding tumor necrosis factor alpha (TNF&agr;) in various species and/or of genes under its control.
    Type: Application
    Filed: March 1, 2004
    Publication date: July 15, 2004
    Inventors: Jacques Pourel, Jean-Yves Jouzeau, Isabelle Chary-Valckenaere, Amr Abid, Horea Porumb, Eliane Taillandier, Patrick Netter